About the GLP-1 Blood Test

Purpose of the test

This panel monitors the safety and effectiveness of GLP-1 receptor agonist medications. It also sets a baseline before you start them. GLP-1 medications are approved for two main uses: managing type 2 diabetes and supporting chronic weight management. The National Institute of Diabetes and Digestive and Kidney Diseases lists GLP-1 receptor agonists among the prescription medications used to treat overweight and obesity.

These medications affect multiple body systems: metabolic, cardiovascular, thyroid, and renal. Regular labs catch problems before symptoms show up.

Baseline testing matters for a specific reason. Labs drawn before you start document your kidney, liver, and thyroid status at the outset. If something changes after you begin the medication, your provider can tell whether it’s a drug effect or something that was already there.

A “GLP-1 blood test” doesn’t measure your body’s own GLP-1 hormone levels. Direct GLP-1 peptide assays exist in research settings but aren’t part of standard clinical practice. The panel covered here tracks how GLP-1 medications affect your body.

The panel serves two purposes:

Baseline assessment: Establishing pre-treatment organ function and metabolic status before starting GLP-1 therapy
Monitoring: Tracking how key biomarkers change over time in people actively using GLP-1 medications

The panel doesn’t diagnose diabetes, thyroid disease, kidney disease, or liver disease on its own. Results need to be read alongside your symptoms, medication type, dose, and medical history.

What does the GLP-1 blood test measure?

This panel covers eight markers from a single visit at a CLIA-certified (Clinical Laboratory Improvement Amendments) lab, combining blood and urine samples.

Metabolic Markers

Hemoglobin A1c Test: Measures the percentage of hemoglobin coated with sugar, reflecting your average blood glucose over two to three months.
Glucose Test: Measures glucose (sugar) circulating in your blood at the time of the draw.
Comprehensive Metabolic Panel (CMP): 14-component panel measuring:
Glucose: Measures blood sugar, a key marker of how your body processes energy.
Calcium: Measures calcium in your blood, which supports muscle, nerve, and bone function.
Sodium: Measures sodium, an electrolyte that helps regulate fluid balance and nerve function.
Potassium: Measures potassium, an electrolyte essential for heart and muscle function.
Bicarbonate (CO2): Measures bicarbonate, which reflects your body’s acid-base balance.
Chloride: Measures chloride, an electrolyte that works with sodium to maintain fluid balance.
Blood urea nitrogen (BUN): Measures urea nitrogen, a waste product that shows how well your kidneys are filtering.

Albumin: Measures the main protein made by your liver, which helps keep fluid in your bloodstream.
Total protein: Measures the combined level of albumin and globulin proteins in your blood.
ALT (alanine aminotransferase): Measures a liver enzyme that rises when liver cells are damaged.
AST (aspartate aminotransferase): Measures an enzyme in the liver, heart, and muscle that can signal tissue injury.
ALP (alkaline phosphatase): Measures an enzyme linked to the liver, bile ducts, and bone.
Total bilirubin: Measures the yellow pigment produced when red blood cells break down, processed by the liver.

Lipid Panel

Lipid/Cholesterol Panel: Measures total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein), and triglycerides.

Thyroid

Thyroid Panel with TSH (Thyroid Stimulating Hormone): 4-component panel measuring:
TSH (thyroid-stimulating hormone): Measures the hormone your pituitary gland releases to tell your thyroid how much hormone to make.
T3 uptake: Measures how much thyroid hormone-binding capacity is available in your blood.
T4 (thyroxine): Measures the main hormone your thyroid produces, which regulates metabolism.
T7 (Free Thyroxine Index): A calculated value combining T3 uptake and T4 to estimate available thyroid hormone.

Other Markers

hCG, Total, Quantitative, Blood (hCG): Measures human chorionic gonadotropin, used to screen for pregnancy or certain tumor markers.

Blood Count

Complete Blood Count with Differential (CBC): 10-component panel measuring:
Red blood cell count (RBC): Counts red blood cells, which carry oxygen to your tissues.
White blood cell count (WBC): Counts white blood cells, your body’s main infection-fighting cells.
Hemoglobin: Measures the protein inside red blood cells that carries oxygen.
Hematocrit: Measures what percentage of your blood volume is red blood cells.
Mean corpuscular volume (MCV): Measures the average size of your red blood cells.
Mean corpuscular hemoglobin (MCH): Measures the average hemoglobin inside each red blood cell.
Mean corpuscular hemoglobin concentration (MCHC): Measures the average hemoglobin concentration within red blood cells.
Red cell distribution width (RDW): Measures how much your red blood cells vary in size.
Platelet count: Counts platelets, which help your blood clot after an injury.
White blood cell differential (neutrophils, lymphocytes, monocytes, eosinophils, basophils): Breaks down five types of white blood cells to show which are high or low.

Routine Chemistry

Routine Urinalysis: 12-component panel measuring:
Color: Notes urine color, which can reflect hydration and kidney health.
Appearance: Checks whether urine looks clear or cloudy, which can signal infection.
Specific gravity: Measures how concentrated your urine is, reflecting hydration and kidney function.
pH: Measures how acidic or alkaline your urine is.
Protein: Detects protein in urine, which can indicate kidney stress or damage.
Glucose: Detects sugar in urine, which can appear when blood glucose is high.
Ketones: Detects ketones, produced when your body burns fat for fuel.
Occult blood: Detects blood in urine that isn’t visible to the naked eye.
Leukocyte esterase: Detects an enzyme from white blood cells that can signal a urinary tract infection.
Nitrite: Detects nitrites that certain bacteria produce, which can indicate infection.
Bilirubin: Detects bilirubin in urine, which can signal liver problems.
Urobilinogen: Measures a byproduct of bilirubin breakdown that can reflect liver and red blood cell health.

When should I get a GLP-1 blood test?

Consider testing if any of these apply:

Currently taking semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza), or a similar GLP-1 medication
Planning to start GLP-1 therapy with no recent baseline labs
Living with type 2 diabetes or prediabetes and managing it with medication
Enrolled in a medically supervised weight management program involving GLP-1 medications
Experiencing new or worsening symptoms on GLP-1 therapy, such as persistent nausea, stomach pain, or unusual fatigue
Carrying a family history of thyroid cancer, pancreatitis, or kidney disease before starting GLP-1 medications
Lacking recent metabolic labs when your provider recommends a baseline

For routine monitoring, clinical guidance supports this schedule:

Circumstance

Suggested interval

Before starting GLP-1 therapy

Baseline panel

Three months after starting

First follow-up

Stable treatment

Every three to six months

Blood sugar not at goal or dose being adjusted

Every three months

Not on GLP-1 medications, monitoring metabolic risk

Annually

The American Diabetes Association’s Standards of Medical Care in Diabetes recommends HbA1c testing every three months when blood sugar is not at goal or when therapy is being adjusted, and at least twice yearly for patients who are meeting treatment targets.

If you have a history of pancreatitis, talk with your provider before starting GLP-1 therapy. These medications carry a risk of pancreatitis, and baseline labs help spot pre-existing concerns that might affect medication selection.

How It Works

How to get tested

This panel is ordered through a healthcare provider, clinic, or hospital lab. Testing.com connects users with CLIA-certified laboratory partners including LabCorp and Quest Diagnostics for in-lab blood draws. Your provider orders the panel, you visit a nearby patient service center or the provider’s office for the blood draw and urine sample, and results come back through the ordering provider’s patient portal.

Some providers include this panel as part of routine diabetes or weight management follow-up visits. Others write a separate lab order. The collection process is the same either way.

Before the test

Fast for eight to 12 hours before your appointment. Water is fine. Skip food, coffee, juice, and other beverages. Both glucose and lipid readings are affected by recent food.
Keep taking your prescribed medications unless your provider says otherwise. GLP-1 medications don’t need to be stopped before monitoring labs.
Avoid strenuous exercise for 24 hours before the blood draw. Intense activity temporarily raises creatinine, which makes kidney function results harder to read.
Schedule a morning appointment if you can. Morning draws make fasting easier.
Tell your provider about any vitamins, supplements, or over-the-counter medications you take. Some affect liver enzymes or lipid readings.
Drink water normally up to your appointment. Dehydration affects kidney markers and can make the blood draw harder.

During the test

A phlebotomist draws blood from a vein in your arm. You’ll feel a brief pinch. Multiple tubes are filled in a single draw because the panel covers eight tests. You’ll also provide a urine sample for the urinalysis. The lab gives you a collection cup and instructions.

A small bandage covers the draw site. The whole visit takes about five to 10 minutes.

Some people feel lightheaded after fasting. Sit for a few minutes before leaving if that happens. Keep the bandage on for at least 15 minutes, and eat something after you leave.

Call your provider if you notice lasting pain, swelling, or spreading bruising at the draw site.

After the test

Results are typically ready within one to three business days after the lab receives your sample, though timing can vary by lab. Some tests, particularly the CBC, may return earlier than others in the panel. Weather, holidays, or high lab volume can extend turnaround.

Results are delivered through the ordering provider’s patient portal or office.

What Do My Results Mean?

Your results come back as numeric values, each with its own reference range. No single number tells the whole story. Results are most meaningful as trends over time: one slightly out-of-range value matters less than a consistent pattern across multiple tests.

Your medication type, dose, how long you’ve been on it, recent weight changes, symptoms, and medical history all affect how your provider reads your numbers. The panel doesn’t diagnose any condition by itself.

HbA1c as the primary effectiveness marker:

As described by MedlinePlus, the HbA1c test reflects average blood glucose over the past two to three months and is a key tool for monitoring diabetes management.

HbA1c Result

What It May Indicate

Typical Next Step

Below 5.7%

Normal blood sugar

Continue current lifestyle and monitoring

5.7% to 6.4%

Prediabetes range

Lifestyle changes; discuss options with provider

6.5% to 7.0%

Diabetes, good control

Maintain current treatment plan

Above 7.0%

Diabetes, may need improvement

Discuss medication adjustment with provider

Reference ranges may vary between labs. Review results with your provider.

A few other markers worth understanding in the GLP-1 context:

Kidney function (creatinine, BUN): GLP-1 medications can affect how your kidneys clear waste. A rising creatinine trend over multiple tests warrants a closer look.

Liver enzymes (ALT, AST): Mild, temporary rises can happen with rapid weight loss. That’s a medication effect, not necessarily liver damage. Persistent or large increases need follow-up.

TSH: Values outside the normal range need thyroid follow-up. According to the FDA’s prescribing information for semaglutide, GLP-1 receptor agonists carry a black box warning about thyroid C-cell tumor risk observed in animal studies. An abnormal TSH doesn’t mean cancer. It means more testing.

Lipid panel: Improving LDL and triglyceride trends are expected with effective GLP-1 therapy. Worsening trends may mean you need added intervention.

If your results are within normal range

Your medication is working safely and your body is tolerating treatment well. A declining HbA1c trend, say dropping from 8.2% to 7.1% over two testing cycles, is a strong signal of effectiveness. Normal kidney and liver values confirm the medication isn’t stressing those organs.

Keep your monitoring schedule. Normal results don’t mean testing can stop.

If your results are outside normal range

Don’t change your medication on your own. Share results with your provider first: some changes are expected effects of treatment, not signs of harm.

Specific scenarios to discuss with your provider:

HbA1c above 7.0% after three to six months: A dose adjustment or medication change may be worth discussing.
Rising creatinine: Kidney function needs closer monitoring. Your provider may adjust your dose.
TSH outside normal range: Thyroid follow-up is needed. As noted in the Mayo Clinic’s semaglutide precautions guidance, GLP-1 medications are contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Worsening lipid panel: May point to a need for added cardiovascular support.

One trend matters more than any single result. A consistent worsening pattern across multiple testing cycles is more meaningful than one value that’s slightly off.

FAQs

Is this the same as testing my GLP-1 hormone levels?

No. This panel tracks how GLP-1 medications affect your body. It doesn’t measure your body’s own GLP-1 hormone levels. Direct GLP-1 peptide assays exist in research settings but aren’t standard clinical practice.

Can a blood test tell me if I'm a good candidate for GLP-1 medications?

Baseline labs help identify conditions that affect medication selection. Key markers include kidney function, liver enzymes, TSH, HbA1c, and the lipid panel for cardiovascular risk context. But labs alone don’t determine candidacy: your BMI, medical history, and a clinical evaluation are part of the picture too.

Do GLP-1 medications affect lab results in ways that could be misread?

Yes. GLP-1 medications slow stomach emptying, which can affect how fast glucose is absorbed and may shift fasting glucose timing. Rapid weight loss from GLP-1 therapy can also temporarily raise liver enzymes (ALT, AST). That’s a medication effect, not necessarily liver damage. Always tell your provider you’re on a GLP-1 medication when reviewing results.

Can I take this test if I haven't started GLP-1 medications yet?

Yes. Baseline testing before starting is one of the main reasons to get this panel. It documents your kidney, liver, and thyroid status before treatment begins. That baseline helps your provider tell whether changes after starting are drug effects or something already present.

What should I do if my thyroid results are abnormal?

Tell your provider right away. GLP-1 receptor agonists are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2. An abnormal TSH doesn’t mean thyroid cancer. It means follow-up testing is needed.

How is this panel different from a standard diabetes blood test?

A standard diabetes blood test, like an HbA1c or fasting glucose alone, checks blood sugar only. This panel adds kidney function, liver health, thyroid monitoring, cholesterol, blood cell counts, and urinalysis. That broader scope is what makes it a monitoring panel rather than a single-marker test.